Breast Ca overdiagnosed in 1 in 10 middle-aged women
July 1st 2006About 1 in 10 women between the ages of 55 and 69 who is diagnosed with breast cancer is diagnosed unnecessarily because her disease would never have come to clinical attention if she were not screened. The findings come 15 years after the end of the population-based Swedish Malm? mammographic screening trial, a randomized, controlled trial of over 40,000 women.
C-section important risk factor for placenta previa/abruption
July 1st 2006A cesarean first birth increases the risks for placenta previa and placenta abruption in subsequent pregnancies. So does a short interpregnancy interval, according to a retrospective cohort study of almost 200,000 singleton pregnancies.
Explaining ovulation awareness-based family planning methods
July 1st 2006These easily taught birth control methods may be just what some patients are looking for. Nonhormonal approaches like the Standard Days and the TwoDay Methods hinge on identifying a woman's fertile window: the days during her cycle when pregnancy is likely.
Grand Rounds: Hysterectomy sans oophorectomy: The case for leaving a woman's ovaries alone
July 1st 2006If there's no cancer present, why remove a woman's ovaries during hysterectomy? Does the reduced risk of ovarian cancer outweigh the consequences of eliminating the protective hormones secreted by a healthy pair of ovaries? A team of researchers offers some thought-provoking conclusions.
New Studies Examine Treatments, Causes and Risks for Women with PCOS
June 22nd 2006New research presented today on treatments, causes and risks associated with Polycistic Ovary Syndrome (PCOS), a disease that effects between five and 10 percent of reproductive aged women, offers a glimmer of hope to the millions of women who suffer from the painful and debilitating disease.
Prescribing Patterns in Premenstrual Syndrome
June 20th 2006Over 300 therapies have been proposed for premenstrual syndrome. To date there has been only one survey conducted in the UK of PMS treatments prescribed by GPs, a questionnaire-based study by the National Association of Premenstrual Syndrome in 1989.
Using aromatase inhibitors to stimulate a woman's ovaries
June 1st 2006Although clomiphene citrate and FSH remain the mainstay of therapy for ovarian stimulation among women with unexplained infertility, both drugs have their shortcomings. Two experts present the evidence supporting the value of AIs in this patient population.
Demystifying combined HPV-Pap screening guidelines, Part 2
June 1st 2006A leading expert helps you educate yourself-and your patients-about putting combined HPV-Pap testing into practice. Patient education should stress how common HPV is and explain the high level of reassurance testing negative on both tests affords.
Ovarian Ca risk assessment tool has potential
June 1st 2006Using a risk assessment score that incorporates CA 125 values, prealbumin, and menopausal status may help predict which women presenting with a pelvic mass are most likely to have ovarian cancer, according to this prize-winning paper presented at the 2006 ACOG clinical meeting in Washington, D.C.
Using liquid Pap tests to detect gonorrhea and chlamydia
June 1st 2006You can accurately test for Neisseria gonorrheae (NG) and Chlamydia trachomatis (CT) using the same liquid Pap specimens collected for cervical cytology, researchers from University of Oklahoma college of Medicine in Tulsa have concluded.